Intercept Pharmaceuticals

Listing Websites about Intercept Pharmaceuticals

Filter Type:

Homepage - Intercept Pharmaceuticals

(2 days ago) Intercept provides this link as a service to its website visitors. Intercept is not responsible for the content or the privacy policy of any third party websites. Close this window to return to Intercept Pharmaceuticals’ site or click ‘Continue’ to proceed.

Interceptpharma.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals, Inc. (ICPT) Stock Price, News

(6 days ago) Find the latest Intercept Pharmaceuticals, Inc. (ICPT) stock quote, history, news and other vital information to help you with your stock trading and investing.

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals Medical Information

(3 days ago) Intercept Medical Information. We strive to provide timely, high-quality, accurate, and unbiased scientific information about our products and our research. This information is not intended as medical advice or clinical recommendations.

Interceptmedinfo.com

Category:  Health Detail Drugs


ICPT Stock Price Intercept Pharmaceuticals Inc. Stock

(8 days ago) Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development and commercialization of novel therapeutics in treating chronic liver diseases.

Marketwatch.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals, Inc. (ICPT) Stock Price Today

(6 days ago) Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States

Seekingalpha.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals - Crunchbase Company Profile

(5 days ago) Intercept Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering and developing small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases. It offers INT-747, a FXR modulating agent that treats patients with chronic autoimmune liver diseases.

Crunchbase.com

Category:  Pharmaceutical Detail Drugs


OCALIVA® (obeticholic acid) – Official Patient Website

(4 days ago) I agree to receive information from Intercept Pharmaceuticals about the diseases it treats and its products and services. I understand that my information may be used by Intercept, and companies working with Intercept, for marketing purposes; to conduct market research; and to develop future products, services and programs.

Ocaliva.com

Category:  Pharmaceutical Detail Drugs


ICPT Intercept Pharmaceuticals, Inc. — Stock Price and

(4 days ago) Intercept Pharmaceuticals, Inc. NASDAQ Updated Oct 14, 2021 9:44 PM ICPT 17.78 0.32 (1.83%). Post-Market 0.05 (0.28%)

Stocktwits.com

Category:  Pharmaceutical Detail Drugs


ICPT: Intercept Pharmaceuticals Inc - Stock Price, Quote

(2 days ago) Intercept Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat progressive non-viral liver diseases with

Cnbc.com

Category:  Pharmaceutical Detail Drugs


ICPT Stock Forecast, Price & News (Intercept Pharmaceuticals)

(6 days ago) Intercept Pharmaceuticals' stock was trading at $77.60 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ICPT stock has decreased by 79.3% and is now trading at $16.06. View which stocks have been most impacted by COVID-19.

Marketbeat.com

Category:  Pharmaceutical,  Health Detail Drugs


Job Postings - Intercept Pharmaceuticals

(Just Now) Intercept provides this link as a service to its website visitors. Intercept is not responsible for the content or the privacy policy of any third party websites. Close this window to return to Intercept Pharmaceuticals’ site or click ‘Continue’ to proceed. Continue

Interceptpharma.submit4jobs.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) Is A Safe

(3 days ago) Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) shares, rose in value on Friday, 10/15/21, with the stock price down by -5.40% to the previous day’s close as strong demand from buyers drove the stock to $16.82. Actively observing the price movement in the last trading, the stock closed the session at

Stocksregister.com

Category:  Pharmaceutical Detail Drugs


Working at Intercept Pharmaceuticals: Employee Reviews

(Just Now) Intercept Pharmaceuticals insights. Based on 10 survey responses. What people like. Time and location flexibility. Feeling of personal appreciation. Ability to meet personal goals. Areas for improvement. Overall satisfaction. Clear sense of purpose.

Indeed.com

Category:  Pharmaceutical Detail Drugs


Why Intercept Pharmaceuticals Stock Shed 19% of Its Value

(3 days ago) Shares of the small-cap biotech Intercept Pharmaceuticals (NASDAQ:ICPT) sank by a noteworthy 19% during the first six months of 2021, according to data from S&P Global Market Intelligence. The

Fool.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals, Inc. (ICPT) Income Statement

(7 days ago) Get the detailed quarterly/annual income statement for Intercept Pharmaceuticals, Inc. (ICPT). Find out the revenue, expenses and profit or loss over the last fiscal year.

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals, Inc. Common Stock (ICPT) News

(5 days ago) Aug 20, 2021. Intercept Pharma Continues Downtick. Aug 10, 2021. 5 Growth Stocks With 110% to 393% Upside, According to Wall Street. Jul 30, 2021. Intercept Pharmaceuticals, inc (ICPT) Q2 2021

Nasdaq.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals LinkedIn

(8 days ago) Intercept Pharmaceuticals 46,226 followers on LinkedIn. Our mission is to build a healthier tomorrow for patients with progressive non-viral liver diseases. We are a …

Linkedin.com

Category:  Pharmaceutical,  Health Detail Drugs


Intercept Pharmaceuticals, Inc. - ICPT - Stock Price Today

(2 days ago) Company Summary. New York, NY-based Intercept Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing novel therapeutics to treat chronic liver diseases to market. The company’s

Zacks.com

Category:  Pharmaceutical Detail Drugs


What This FDA Update Means for Intercept Pharma – 24/7

(1 days ago) Intercept Pharmaceuticals stock was crushed early on Monday after the firm received an update from the FDA in regards to its treatment …

247wallst.com

Category:  Pharmaceutical Detail Drugs


Working at Intercept Pharmaceuticals Glassdoor

(3 days ago) Glassdoor gives you an inside look at what it's like to work at Intercept Pharmaceuticals, including salaries, reviews, office photos, and more. This is the Intercept Pharmaceuticals company profile. All content is posted anonymously by employees working at Intercept Pharmaceuticals.

Glassdoor.com

Category:  Pharmaceutical Detail Drugs


ICPT - Intercept Pharmaceuticals Inc Stock quote

(8 days ago) Find real-time ICPT - Intercept Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.

Money.cnn.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals, Inc. Common Stock (ICPT) Stock

(Just Now) Intercept Pharmaceuticals, inc (ICPT) Q2 2021 Earnings Call Transcript. The Motley Fool • Jul 30, 2021.

Nasdaq.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals Careers and Employment Indeed.com

(2 days ago) Find out what works well at Intercept Pharmaceuticals from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular roles and read about the team’s work-life balance. Uncover why Intercept Pharmaceuticals is the best company for you.

Indeed.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals: Strong Biopharmaceutical IPO

(4 days ago) Intercept Pharmaceuticals (NASDAQ:ICPT) made its public debut on Thursday. Shares of the biopharmaceutical company focused on novel therapeutics treating chronic liver diseases, ended their first

Seekingalpha.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals Revenue 2011-2021 ICPT

(Just Now) Intercept Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat chronic liver disease. The company's lead product candidate, obeticholic acid, or OCA, is a bile acid analog and first-in-class agonist of the farnesoid X receptor (FXR).

Macrotrends.net

Category:  Pharmaceutical Detail Drugs


3 Biotech Stocks to Bank on for Buyouts in 2020: ARWR

(4 days ago) Intercept Pharmaceuticals (ICPT) Source: Shutterstock. Non-alcoholic SteatoHepatitis (NASH) remains a tough nut to crack. The progressive liver disease can destroy the organ, and is projected to

Investorplace.com

Category:  Pharmaceutical Detail Drugs


INTERCEPT PHARMACEUTICALS, INC. : ICPT Stock Price

(8 days ago) Intercept Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. The Company's product candidates have the potential to treat orphan and more prevalent diseases for which there are limited therapeutic solutions.

Marketscreener.com

Category:  Pharmaceutical Detail Drugs


Profile for Intercept Pharmaceuticals, Inc - DrugChatter

(4 days ago) DrugPatentWatch Video Training Decision-making for generic drug entry and branded drug lifecycle management Start Learning Today. By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these …

Drugchatter.com

Category:  Health Detail Drugs


Primary Biliary Cholangitis Treatment – OCALIVA

(3 days ago) OCALIVA is a primary biliary cholangitis (PBC) treatment used with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or alone in adults unable to tolerate UDCA. See Full Prescribing Information and Boxed Warning. Also see …

Ocalivahcp.com

Category:  Health Detail Drugs


Intercept Pharmaceuticals, Inc. - TheStreet

(6 days ago) Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development and commercialization of novel therapeutics in treating chronic liver diseases.

Thestreet.com

Category:  Pharmaceutical Detail Drugs


ICPT Intercept Pharmaceuticals Inc. Profile MarketWatch

(4 days ago) Intercept Pharmaceuticals Inc. 10 Hudson Yards. 37th floor. New York, New York 10001. Phone 1 646 747-1000. Industry Biotechnology. Sector Health Care/Life Sciences.

Marketwatch.com

Category:  Pharmaceutical,  Health Detail Drugs


ICPT Intercept Pharmaceuticals Inc. Stock Overview (U.S

(7 days ago) Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development and commercialization of novel therapeutics in treating chronic liver diseases.

Barrons.com

Category:  Pharmaceutical Detail Drugs


Director, Regulatory Labeling Lead - Intercept Pharmaceuticals

(1 days ago) Intercept Pharmaceuticals. San Diego, CA. Apply Now. JOB DETAILS. LOCATION. San Diego, CA. POSTED. 30+ days ago. Description. COMPANY SUMMARY: At Intercept, our mission is to build a healthier tomorrow for patients with progressive non-viral liver diseases. Intercept’s lead product, obeticholic acid (OCA), is a first-in-class farnesoid X

Monster.com

Category:  Pharmaceutical,  Health Detail Drugs


Intercept Pharmaceuticals (NasdaqGS:ICPT) - Share price

(3 days ago) Intercept Pharmaceuticals, Inc. announced a financing transaction. Intercept Pharmaceuticals, Inc. announced that it has entered into subscription agreements for a private placement of newly-issued 3.5% convertible senior secured notes due 2026 for gross proceeds of $117.6 million on August 10, 2021.

Simplywall.st

Category:  Pharmaceutical Detail Drugs


ICPT.OQ - Intercept Pharmaceuticals Inc Profile Reuters

(1 days ago) Intercept Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. The

Reuters.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals Jobs Glassdoor

(3 days ago) Intercept Pharmaceuticals Inc. San Diego, CA. $70K-$120K. Manager/Senior Manager, Quality Assurance GCP. Intercept Pharmaceuticals Inc. New York, NY. $82K-$149K. Associate Director, Biostatistics. Intercept Pharmaceuticals Inc.

Glassdoor.com

Category:  Pharmaceutical Detail Drugs


ICPT News Today (Intercept Pharmaceuticals) MarketBeat

(1 days ago) Intercept Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update finance.yahoo.com - July 29 at 9:40 AM: Earnings Outlook For Intercept Pharmaceuticals benzinga.com - July 28 at 5:29 PM: Why Intercept Pharmaceuticals Stock Shed 19% of Its Value in the First Six Months of 2021 finance.yahoo.com - July 19 at 1

Marketbeat.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals, (ICPT) - Forbes

(9 days ago) Intercept Pharmaceuticals, Inc. is a development stage biopharmaceutical company. It focuses on the discovering, developing and commercializing of novel therapeutics to treat chronic liver

Forbes.com

Category:  Pharmaceutical Detail Drugs


INTERCEPT PHARMACEUTICALS, INC. Executive Salaries & Other

(8 days ago) INTERCEPT PHARMACEUTICALS, INC. income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. INTERCEPT PHARMACEUTICALS, INC. annual reports of executive compensation and pay are …

Www1.salary.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) Shares Are

(9 days ago) Intercept Pharmaceuticals Inc. share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -33.39 percent over the past six months and at a 53.60% annual growth rate that is well above the industry average of 7.40%.

Marketingsentinel.com

Category:  Pharmaceutical Detail Drugs


ICPT Stock - Intercept Pharmaceuticals, Inc. SEC Filings

(Just Now) Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. OCA was approved as Ocaliva to treat primary biliary cirrhosis in 2016 and is being developed for a variety of chronic liver diseases

Sec.report

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals Market Cap ICPT

(5 days ago) Intercept Pharmaceuticals Announces Convertible Notes Exchange, New Issuance and Stock Repurchase Globe Newswire 08/10 21:43 ET. 5 Growth Stocks With 110% to 393% Upside, According to Wall Street Yahoo 08/10 06:06 ET--B. Riley Raises Intercept Pharmaceuticals' PT to $22 from $18 After Q2 Results Beat Estimates, Keeps Neutral Rating

Ycharts.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals Inc. (ICPT) Reveals an Earnings

(7 days ago) Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) went down by -6.14% from its latest closing price compared to the recent 1-year high of $50.75. The company’s stock price has collected -12.94% of loss in the last five trading sessions. Press Release reported on 08/10/21 that Intercept Pharmaceuticals Announces Convertible Notes Exchange, New Issuance and …

Newsheater.com

Category:  Pharmaceutical Detail Drugs


Earnings Preview: Intercept Pharmaceuticals - Benzinga

(6 days ago) Sell-side analysts are expecting Intercept Pharmaceuticals's loss per share to be near $1.44 on sales of $81.20 million. In the same quarter last year, Intercept Pharmaceuticals reported a loss

Benzinga.com

Category:  Pharmaceutical Detail Drugs

Filter Type:


Popular Searched

 › Drug bust in pa

 › Medical assistant study book

 › Boulder medical center broadway

 › State exam for medical assistant

 › Printable drug and alcohol quizzes

 › Ima medical group corporate

 › Federal income tax medical expenses

 › Medical laboratory technologist exam

 › Ima medical group fl

 › Pharmacy tech study games

Recently Searched

 › Va hospital raeford rd fayetteville nc

 › Walmart pharmacy phoenix az

 › Louis & clark medical supply springfield

 › Alabama internal medicine trussville

 › Adderall and prozac drug interactions

 › Wellcare medicare formulary drug list

 › Dot drug testing sites

 › Biotin interaction with other drugs

 › Drug awareness knowledge quiz answers

 › Multicare health system medical records

FAQ about Intercept Pharmaceuticals

What kind of company is Intercept Pharmaceuticals Inc?

Intercept Pharmaceuticals Inc. Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis,...

What's the stock price of ICPT Intercept Pharmaceuticals?

$ICPT Form SC TO-C (written communication relating to an issuer or third party) filed with the SEC newsfilter.io/a/463c38ff8fd... $ICPT Intercept's shares trading at less than two times 2022 sales at current levels which is dirt cheap valuation for a biotech stock.

Why is Intercept Pharmaceuticals stock going up or down?

Biotechs Can’t Cure This Liver Disease. The Latest Failure Crushed the Sector. Biogen Stock Is Jumping. The Biotech Submitted Its Troubled Alzheimer’s Drug for FDA Approval. Analysts Are Downgrading Intercept Pharmaceuticals. Here’s Why. Intercept (ICPT) Moves 8% Higher: Will This Strength Last?

When do Intercept Pharmaceuticals report second quarter results?

NEW YORK , July 19, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its second quarter 2021 financial results prior